Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Takashi Nakanoma is active.

Publication


Featured researches published by Takashi Nakanoma.


International Journal of Urology | 1999

Laparoscopic treatment of retroperitoneal benign schwannoma

Takashi Ohigashi; Shoichi Nonaka; Takashi Nakanoma; Munehisa Ueno; Nobuhiro Deguchi

Purpose/Methods: We report on a case of retroperitoneal benign schwannoma treated by laparoscopic surgery.


International Journal of Urology | 2000

Simultaneous production of granulocyte colony-stimulating factor and parathyroid hormone-related protein in bladder cancer

Munehisa Ueno; Shin-Ichi Ban; Takashi Ohigashi; Takashi Nakanoma; Shoichi Nonaka; Risa Hirata; Masahiro Iida; Nobuhiro Deguchi

A case of bladder cancer with simultaneous production of granulocyte colony‐stimulating factor (G‐CSF) and parathyroid hormone‐related protein (PTHrP) is reported. An 81‐year‐old male patient was admitted to the Saitama Medical School for treatment of gross hematuria, leukocytosis and hypercalcemia and diagnosed as having advanced bladder cancer. Immediately after a cystectomy was carried out, his white cell count and serum calcium levels returned to normal. However, the tumors recurred locally and the recurrence was accompanied by an increase in the serum G‐CSF and PTHrP levels with a recurrent elevation of white cell count and the serum calcium level. The production of G‐CSF and PTHrP in the tumor cells was confirmed by immunohistochemistry.


Urologia Internationalis | 2007

Prostate Cancer Screening with Prostate-Specific Antigen in Hemodialysis Patients

Minoru Horinaga; Koji Kitamura; Shiro Saito; Osamu Ukimura; Takashi Nakanoma; Koji Okihara; Motonobu Kitagawa; Hiroyuki Nakanishi; Tsuneharu Miki

Background/Aims: The diagnostic validity of prostate-specific antigen (PSA) among men receiving hemodialysis (HD) has not been well defined. The aim of this study was to evaluate PSA levels in HD men and to compare them with those of non-uremic controls. Methods: PSA levels were measured in 620 HD men (40–89 years old, mean age 62.4 years). In patients with PSA >4.1 ng/ml, prostate biopsies were performed. Cancer-free men were defined as having PSA ranging between 0 and 4.0 ng/ml, or PSA >4.1 ng/ml but with a pathologically negative biopsy. The resulting data was compared with that for 3,636 non-uremic controls (55–59- (n = 468), 60–69- (n = 2,220), and 70–79-year-old men (n = 948)). Results: Of 45 HD men with PSA >4.1 ng/ml, 22 consented to undergo a biopsy. Ten were positive and 12 were negative. The mean PSA of cancer-free HD men of 50–59 (n = 159), 60–69 (n = 214), 70–79 (n = 116), and 80–89 (n = 30) were 1.0, 1.0, 1.3, and 2.1 ng/ml, respectively. Cancer-free HD men demonstrated significantly lower PSA compared to controls. Conclusions: HD men had lower PSA levels than those of controls.


International Journal of Urology | 2001

Characterization of a newly established cell line derived from human adrenocortical carcinoma

Munehisa Ueno; Jun Nakashima; Masumi Akita; Shin-Ichi Ban; Takashi Nakanoma; Masahiro Iida; Nobuhiro Deguchi

Abstract Background: ACT‐1, a new cell line of human adrenocortical carcinoma, has been established and successfully maintained in culture. This study examined the biological characteristics of the cells.


International Journal of Urology | 2000

Hypercalcemia in a patient with renal cell carcinoma producing parathyroid hormone‐related protein and interleukin‐6

Munehisa Ueno; Shin-Ichi Ban; Takashi Nakanoma; Takuji Tsukamoto; Shoichi Nonaka; Risa Hirata; Masahiro Iida; Nobuhiro Deguchi

A patient with renal cell carcinoma who developed humoral hypercalcemia of malignancy is reported. A 52‐year‐old male patient was diagnosed with renal cell carcinoma and multiple lung metastases. A cell line isolated from the surgical specimen exhibited continuous production of parathyroid hormone‐related protein (PTHrP) in vitro. The production of PTHrP from the cancer cells was confirmed by RT‐PCR and immunoradiometric assay. The serum calcium level was not enhanced, whereas the lung lesion was developing and producing interleukin‐6, a possible modulator of osteoclastic resorption. Hypercalcemia was induced when the PTHrP concentration increased up to 3.3 pmol/L.


International Journal of Urology | 1999

Suppression of default apoptosis in androgen‐dependent cells by testosterone‐mediated bcl‐2 expression

Takashi Ohigashi; Munehisa Ueno; Masahiro Iida; Risa Hirata; Takashi Nakanoma; Nobuhiro Deguchi

Background: The significance of apoptosis with regard to the development and progression of androgen‐dependent cells has not been clearly understood. In the present study we investigated the expression of the bcl‐2 proto‐oncogene after androgen deprivation and its role in cell growth in an androgen‐dependent cell line.


Urology | 2006

Efficacy compared between caudal block and periprostatic local anesthesia for transrectal ultrasound-guided prostate needle biopsy.

Minoru Horinaga; Jun Nakashima; Takashi Nakanoma


American Journal of Physiology-cell Physiology | 2000

Tyrosine kinase inhibitors reduce bcl-2 expression and induce apoptosis in androgen-dependent cells

Takashi Ohigashi; Munehisa Ueno; Shoichi Nonaka; Takashi Nakanoma; Yusuke Furukawa; Nobuhiro Deguchi; Masaru Murai


The Japanese Journal of Urology | 2001

[Left adrenocortical cancer with inferior vena cava tumor thrombus--a case report].

Takashi Nakanoma; Munehisa Ueno; Shoichi Nonaka; Takuji Tsukamoto; Nobuhiro Deguchi


The Japanese Journal of Urology | 1998

A New Technique of Arteriovenous Fistula with Titanium Clip Appller

Takashi Ohigashi; Shoichi Nonaka; Takashi Nakanoma; Munehisa Ueno; Nobuhiro Deguchi

Collaboration


Dive into the Takashi Nakanoma's collaboration.

Top Co-Authors

Avatar

Nobuhiro Deguchi

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar

Munehisa Ueno

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar

Shoichi Nonaka

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Masahiro Iida

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar

Risa Hirata

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar

Shin-Ichi Ban

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Takuji Tsukamoto

Saitama Medical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge